Advertisement

Topics

Search Results for "Pharmaceutical Company Organization Chart"

19:29 EDT 23rd August 2017 | BioPortfolio

Matching Channels

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry. For more than two decades, the company has led the industry in developing innovative p...

Connecticut

Connecticut, a state in the north-east corner of the US is a hub for biotechnology companies. There are over 100 high-quality companies with global markets based in Connecticut. In 2004, Connectic...

Visual acuity

Visual acuity (VA) is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain. Visu...

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

Matching News

M Pharmaceutical, Inc.: M Pharmaceutical Inc. Engages Camargo Pharmaceutical Services to Develop Regulatory Strategy for Recently Patented Extrinsa for the Treatment of Female Sexual Dysfunction

CINCINNATI, OH / ACCESSWIRE / June 2, 2017 / M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or "M Pharma"), is pleased to announce that it has engaged Camargo Pharmaceutic...

Oasmia Pharmaceutical AB: Issuance of warrants in Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB (publ) (the "Company") resolved, at the Extraordinary General Meeting of the Company on 2 June 2017, to establish two warrant programmes, series 2017:1 and series 2017:2, i...

Zacks Investment Research Lowers Lannett Company, Inc. (LCI) to Hold

According to Zacks, "Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under it...

Zacks Investment Research Downgrades Lannett Company, Inc. (LCI) to Hold

According to Zacks, "Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under it...

Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda

NANJING, China, June 24, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufac...

Chart to Acquire Hudson Products

Enhances Chart’s core platformAdds highly complementary Fans businessStrengthens aftermarket presenceConsistent with Chart’s strategic growth initiativesSignificant cost synergiesEfficient use...

CURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.

OXNARD, Calif., May 24, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development ...

Oasmia Pharmaceutical AB: Oasmia completes set-off private placements of new convertibles in the total amount of SEK 26 million with conversion rate of SEK 8.00

Oasmia Pharmaceutical AB (publ) ("Oasmia" or the "Company") hereby announces that the Company has completed a private placement of a convertible loan in the amount SEK 26,000,000 through a directed...

Matching PubMed Articles

The Large Pharmaceutical Company Perspective.

Pharmaceutical Marketing for Rare Diseases: Regulating Drug Company Promotion in an Era of Unprecedented Advertisement.

A Standardized Arabic Reading Acuity Chart: The Balsam Alabdulkader-Leat Chart.

The aim of this study was to develop and validate the first standardized Arabic continuous text near-visual-acuity chart, the Balsam Alabdulkader-Leat (BAL) chart.

An attribute control chart for a Weibull distribution under accelerated hybrid censoring.

In this article, an attribute control chart has been proposed using the accelerated hybrid censoring logic for the monitoring of defective items whose life follows a Weibull distribution. The product ...

Adaptation of Know, Want to Know, and Learned Chart for Problem-Based Learning.

The KWL (Know, Want to know, Learned) chart was introduced to facilitate student critical thinking in a large, multisite, medical-surgical nursing course that uses problem-based learning.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement